Skye Bioscience (SKYE) Share-based Compensation (2015 - 2026)
Skye Bioscience (SKYE) posted Share-based Compensation of $1.27 million for Q2 2026, down 37.5% from $2.03 million a year earlier and down 15.1% from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Share-based Compensation (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Skye Bioscience was $6.3 million, down 23.6% year-over-year; for FY2025, it came in at $7.77 million, down 6.6% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 91.4% (FY2020 to FY2025).
- In prior years, Skye Bioscience's Share-based Compensation was $8.32 million in FY2024 (+742.3%), $987,510 in FY2023 (+57.0%), $629,032 in FY2022 (-27.6%) and $869,206 in FY2021 (+187.1%).
- The Q2 2026 figure stands as the lowest quarterly Share-based Compensation since Q4 2023.
- On a year-over-year basis, Share-based Compensation has declined in each of the last four quarters, with growth averaging 22.9% over the last seven quarters.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q4 2024, with growth of 252.4%; the weakest was Q3 2022, with a decline of 70.5%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $1.5 million (Q1 2026), $1.62 million (Q4 2025) and $1.91 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Skye Bioscience | 7.07 Mn | 7.07 Mn | - | 1.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 1.62 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 2.20 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | 1.92 Mn |
| Jun 30, 2024 | 1.83 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Dec 31, 2023 | 592,853.00 |
| Sep 30, 2023 | 160,207.00 |
| Jun 30, 2023 | 102,871.00 |
| Mar 31, 2023 | 131,579.00 |
| Dec 31, 2022 | 203,186.00 |
| Sep 30, 2022 | 144,124.00 |
| Jun 30, 2022 | 144,364.00 |
| Mar 31, 2022 | 137,358.00 |
| Dec 31, 2021 | 121,954.00 |
| Sep 30, 2021 | 488,973.00 |
API Access
Skye Bioscience Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();